6
Oct
2026
23
Nov
2026
Sanzyme Biologics
Meet us at
-
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026stand 12J75 -
CPHI India 2026
IICC, Yashobhoomi, Dwarka, Delhi
23 Nov 2026 - 25 Nov 2026stand 2F58
-
Country/Region:India
-
On CPHI since:2026
Products from Sanzyme Biologics (5)
-
Product L-Asparaginase & PEG-L-Asparaginase.
L-asparaginase is an enzyme derived from E.coli, crucial for cancer therapy, primarily utilized in treating acute lymphoblastic leukemia (ALL) and other related malignancies. By targeting and depleting asparagine, a critical amino acid for cancer cell survival, asparaginase disrupts the cancer cells' abili... -
Product Semaglutide & Precursor (P-29)
Semaglutide, a glucagon-like peptide-1 (GLP-1) analogue used to treat diabetes and long-term weight management. Semaglutide Precursor (P-29): The Recombinant P29 peptide is a critical intermediate in the synthesis of Semaglutide. P29 offers superior consistency, purity, and scalability compared to chemica... -
Product SNZ 1969®
SNZ 1969® is Sanzyme Biologics' flagship Bacillus coagulans probiotic, trusted globally for its unique combination of scientific validation, stability and formulation versatility. Backed by over 55 years of documented use, 35 clinical studies and consumption in more than 150 million doses annually across 4... -
Product Bacillus clausii
Bacillus clausii oral suspension is a probiotic supplement administered for the safe and effective management of antibiotic associated diarrhoea in adults and children. Our strain is widely used, well documented, safe and stable spore forming probiotic bacteria which promotes gastrointestinal health Charac... -
Product Insulin Aspart.
Insulin aspart [rDNA origin] is a rapid-acting human insulin analog used to lower blood glucose. It is homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology. Insulin aspart...
